Rezolute (RZLT)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	10.47 mm	10.47 mm	10.47 mm	10.47 mm	10.47 mm	10.47 mm
Cash burn (monthly)	19.97 mm	(no burn)	5.65 mm	5.95 mm	5.34 mm	5.24 mm
Cash used (since last report)	80.39 mm	n/a	22.73 mm	23.96 mm	21.48 mm	21.07 mm
Cash remaining	-69.92 mm	n/a	-12.25 mm	-13.49 mm	-11.01 mm	-10.60 mm
Runway (months of cash)	-3.5	n/a	-2.2	-2.3	-2.1	-2.0

Beta Read what these cash burn values mean

Financial data from Rezolute earnings reports.

Institutional ownership, Q3 2024

RZLT institutional ownership history Ownership history

76.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	61	53	+15.1%
Opened positions	20	52	-61.5%
Closed positions	12	0	NEW
Increased positions	20	0	NEW
Reduced positions	11	0	NEW

13F shares	Current	Prev Q	Change
Total value	185.08 bn	169.06 bn	+9.5%
Total shares	44.18 mm	42.77 mm	+3.3%
Total puts	24.60 k	0.00	NEW
Total calls	1.60 k	1.00 k	+60.0%
Total put/call ratio	15.4	–	–

Largest owners	Shares	Value	Change
FHI Federated Hermes	11.28 mm	$54.70 bn	0.0%
Adage Capital Management	2.84 mm	$15.46 mm	NEW
Vivo Capital	2.80 mm	$13.57 bn	0.0%
Vivo Opportunity Fund	2.80 mm	$15.22 mm	-13.7%
Nantahala Capital Management	2.58 mm	$12.50 bn	-13.8%
Vanguard	1.93 mm	$9.37 bn	+19.4%
BX Blackstone	1.74 mm	$8.46 bn	+0.0%
Altium Capital Management	1.70 mm	$8.24 bn	0.0%
Affinity Asset Advisors	1.70 mm	$8.24 bn	-8.1%
ADAR1 Capital Management	1.57 mm	$7.62 bn	-23.9%

Largest transactions	Shares	Bought/sold	Change
Adage Capital Management	2.84 mm	+2.84 mm	NEW
Alyeska Investment	0.00	-1.09 mm	EXIT
Sphera Funds Management	1.20 mm	-511.06 k	-29.9%
ADAR1 Capital Management	1.57 mm	-492.26 k	-23.9%
Opaleye Management	466.56 k	+466.56 k	NEW
Vivo Opportunity Fund	2.80 mm	-445.14 k	-13.7%
Nantahala Capital Management	2.58 mm	-412.84 k	-13.8%
BlackRock	398.45 k	+398.45 k	NEW
BLK BlackRock	0.00	-365.86 k	EXIT
MS Morgan Stanley	79.03 k	-321.22 k	-80.3%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

RZLT insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
9 Dec 25	Evans Daron	Common Shares	Buy	Acquire P	No	No	5.04	10,549	53.17 k	131,900
18 Dec 24	Evans Daron	Common Shares	Buy	Acquire P	No	No	4.29	10,000	42.90 k	150,900
12 Dec 24	Evans Daron	Common Shares	Buy	Acquire P	No	No	4.6	9,000	41.40 k	140,900
24 Sep 24	Wladimir Hogenhuis	Common Stock	Buy	Acquire P	No	No	4.7	4,259	20.02 k	41,767
23 Sep 24	Evans Daron	Employee Stock Option Common Shares	Grant	Acquire A	No	No	4.79	100,000	479.00 k	100,000

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

HC Wainwright & Co. Reiterates Buy on Rezolute, Maintains $14 Price Target

8 Nov 24

HC Wainwright & Co. analyst Douglas Tsao reiterates Rezolute (NASDAQ:RZLT) with a Buy and maintains $14 price target.

Rezolute Q1 EPS $(0.22) Beats $(0.33) Estimate

7 Nov 24

Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.33) by 33.33 percent. This is a 21.43 percent increase over losses of $(0.28) per share from the same

Wedbush Initiates Coverage On Rezolute with Outperform Rating, Announces Price Target of $12

5 Nov 24

Wedbush analyst Yun Zhong initiates coverage on Rezolute (NASDAQ:RZLT) with a Outperform rating and announces Price Target of $12.

Press releases

From Benzinga Pro

Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

5 Dec 24

REDWOOD CITY, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage biopharmaceutical company dedicated to developing transformative therapies for rare